Cellromax Science Co., Ltd. (KOSDAQ:471820)
South Korea · Delayed Price · Currency is KRW 4,845.00
-105.00 (-2.12%)
At close: Apr 2, 2026
Cellromax Science Market Cap
Cellromax Science has a market cap or net worth of 54.84 billion as of April 2, 2026. Its market cap has decreased by -7.29% in one year.
Market Cap
54.84B
Enterprise Value
47.62B
Revenue
22.18B
Ranking
n/a
PE Ratio
18.56
Stock Price
4,845.00
Market Cap Chart
Since December 13, 2024, Cellromax Science's market cap has decreased from 92.69B to 54.84B, a decrease of -40.83%. That is a compound annual growth rate of -33.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 54.84B | -25.46% |
| Dec 30, 2025 | 73.57B | 28.56% |
| Dec 30, 2024 | 57.23B | -38.25% |
| Dec 13, 2024 | 92.69B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BBIA Co., Ltd. | 78.69B |
| Black Yak I&C Co.,Ltd | 78.15B |
| ERCOHS Agricultural Corporation Co.,Ltd | 74.42B |
| GITSN | 73.30B |
| Laseroptek | 64.64B |
| ALT Co., Ltd. | 64.49B |
| Korea No.14 Special Purpose Acquisition | 54.26B |
| JNB Co., Ltd. | 50.87B |